Prescription Drug Out-of-Pocket Cost Reduction Programs: Incentives and Implications

JAMA Intern Med. 2021 Jun 1;181(6):765-766. doi: 10.1001/jamainternmed.2021.0739.

Authors

Kai Yeung^{1

2}, Stacie B Dusetzina^{3

4}

Affiliations

¹ Kaiser Permanente Washington Health Research Institute, Seattle.
² The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle.
³ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
⁴ Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

PMID: 33779700
DOI: 10.1001/jamainternmed.2021.0739

No abstract available

Publication types

Comment

MeSH terms

Cost Sharing
Health Expenditures
Humans
Motivation
Prescription Drugs*
Prescription Fees

Substances

Prescription Drugs